Ivana Olla
Overview
Explore the profile of Ivana Olla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Diego-Garcia L, Brennan G, Auer T, Menendez-Mendez A, Parras A, Martin-Gil A, et al.
Epilepsia
. 2023 Aug;
64(10):2827-2840.
PMID: 37543852
Objective: Posttranscriptional mechanisms are increasingly recognized as important contributors to the formation of hyperexcitable networks in epilepsy. Messenger RNA (mRNA) polyadenylation is a key regulatory mechanism governing protein expression by...
2.
Olla I, Pardinas A, Parras A, Hernandez I, Santos-Galindo M, Pico S, et al.
Biol Psychiatry
. 2023 Mar;
94(4):341-351.
PMID: 36958377
Background: Schizophrenia (SCZ) is caused by an interplay of polygenic risk and environmental factors, which may alter regulators of gene expression leading to pathogenic misexpression of SCZ risk genes. The...
3.
Olla I, Santos-Galindo M, Elorza A, Lucas J
Front Mol Neurosci
. 2020 Oct;
13:567430.
PMID: 33122998
Huntington's disease (HD) is a fatal degenerative disorder affecting the nervous system. It is characterized by motor, cognitive, and psychiatric dysfunctions, with a late onset and an autosomal dominant pattern...
4.
Conte G, Parras A, Alves M, Olla I, de Diego-Garcia L, Beamer E, et al.
Epilepsia
. 2020 Oct;
61(12):2795-2810.
PMID: 33070315
Objective: Pharmacoresistance and the lack of disease-modifying actions of current antiseizure drugs persist as major challenges in the treatment of epilepsy. Experimental models of chemoconvulsant-induced status epilepticus remain the models...
5.
Polyadenylation of mRNA as a novel regulatory mechanism of gene expression in temporal lobe epilepsy
Parras A, de Diego-Garcia L, Alves M, Beamer E, Conte G, Jimenez-Mateos E, et al.
Brain
. 2020 Jun;
143(7):2139-2153.
PMID: 32594159
Temporal lobe epilepsy is the most common and refractory form of epilepsy in adults. Gene expression within affected structures such as the hippocampus displays extensive dysregulation and is implicated as...
6.
Siano G, Caiazza M, Olla I, Varisco M, Madaro G, Quercioli V, et al.
Front Cell Neurosci
. 2019 Sep;
13:386.
PMID: 31496937
Formation of Tau aggregates is a common pathological feature of tauopathies and their accumulation directly correlates with cytotoxicity and neuronal degeneration. Great efforts have been made to understand Tau aggregation...